Vitamin D3 shows promise for ulcerative colitis in new trial
NCT ID NCT07269223
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This study tests whether taking high-dose vitamin D3 (50,000 IU every two weeks) for 12 weeks can lower inflammation and improve symptoms in adults with moderate ulcerative colitis. Sixty participants will either get vitamin D plus their usual treatment or a placebo plus usual treatment. The goal is to see if vitamin D can be a helpful add-on therapy to better manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Veterinary & Animal Sciences, Lahore
RECRUITINGLahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.